Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
- Citation:
- Ann Oncol vol 23 (1) 86-93
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- T. Reiman R. Lai A. S. Veillard E. Paris J. C. Soria R. Rosell M. Taron S. Graziano R. Kratzke L. Seymour F. A. Shepherd J. P. Pignon P. Seve
- Networks:
- Study
- CALGB-9633
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: